Interferon injection therapy significantly improves the number of common warts on the hands and feet compared with conventional cryotherapy.

Antivirals given for chronic hepatitis B include nucleos(t)ide analog monotherapy and pegylated interferon-alpha therapy, but ...

New self-administration option offers same clinical benefits as Saphnelo IV infusion MISSISSAUGA, ON, April 13, 2026 /CNW/ – Health Canada has granted a Notice of Compliance (NOC) for ...

Within the evolving landscape of peptide science, Thymosin Alpha-1 occupies a distinctive conceptual position. First characterized decades ago as a thymus-associated peptide fragment, it has since bee ...

Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced the presentation of updated data from its Phase 1 trial of ...

Fast Track designation has the potential to facilitate development and accelerate FDA review of imdusiran WARMINSTER, Pa., April 15, 2026 ...

FDA orphan drug designation provides incentives including regulatory support, tax credits, fee exemptions, and seven years of ...

Fast Track designation has the potential to facilitate development and accelerate FDA review of imdusiran WARMINSTER, Pa., April 15, 2026 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABU ...

A team of scientists at The University of Texas Medical Branch (UTMB), led by Nikos Vasilakis, Ph.D., and Peter McCaffrey, MD ...

View Genenta Science SpA Sponsored ADR GNTA stock quote prices, financial information, real-time forecasts, and company news from CNN.

Dyve Biosciences, in collaboration with Moffitt Cancer Center, today reported significant study results for a first-of-its-kind investigational therapy applied to the skin and des ...

Cue Biopharma, Inc. ( CUE) Discusses CUE-401 R&D Progress and Mechanism for Autoimmune and Inflammatory Diseases April 7, 2026 10:00 AM EDT Lucinda Warren - Interim CEO, Interim President,Principal ...